PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

$21.68
+0.43 (+2.02%)
As of Sep 29, 3:20 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +25.8% upside
Low Target $18.57
Average Target $27.28
High Target $35.01
Current Price $21.68
Current
$21.68
Target
$27.28
$18.57 $27.28 avg $35.01
Scenario Analysis
Bear Case
$18.57
-14.3%
Low target
Base Case
$27.28
+25.8%
Avg target
Bull Case
$35.01
+61.5%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$37.50
-42.2% from high
52-Week Low
$18.19
+19.2% from low
Target vs 52W High
$27.28
-27.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.6%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.8%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%